# Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset

> **NCT02854592** · — · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 4000 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** rtPA
- **DRUG:** urokinase

## Key facts

- **NCT ID:** NCT02854592
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-01
- **Primary completion:** 2019-10-30
- **Final completion:** 2019-10-30
- **Target enrollment:** 4000 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02854592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02854592, "Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02854592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*